JOHANNESBURG, Feb 7 (Reuters) - South Africa will suspend
use of the AstraZeneca vaccine in its immunisation
programme while scientists advise on the best way to proceed,
Health Minister Zweli Mkhize said on Sunday.
Mkhize was speaking after trial data showed the AstraZeneca
vaccine offered only limited protection against mild disease
caused by the 501Y.V2 coronavirus variant first identified in
South Africa.
(Reporting by Alexander Winning and Olivia Kumwenda-Mtambo)